Thank you for the fast response!" " "The ease of taking the test, the turn around of the results and the simplicity of the report definitely beat all my expectations." " "I liked the email contact, letting me know what was going on
Weve taken care of the prep so you can focus on results
In a new article published in the latest issue of Primary Care Companion for CNS Disorders, Melissa Perchellet, M.D., Roopa Sethi, M.D., and Satneet Singh, M.D., co-author a study analyzing the use of buprenorphine in chronic pain management in individuals with sickle cell disease
Standard practice includes: Baseline thyroid function tests (TSH and free T4) before initiating GLP-1 therapy Repeat testing at 812 weeks after starting treatment or after dose escalation Regular monitoring every 36 months during active weight loss Return to annual monitoring once weight is stable and thyroid function remains consistent Adjustments to levothyroxine dosing may be necessary as weight changes
Newsome P, Francque S, Harrison S, Ratziu V, Van Gaal L, Calanna S, Hansen M, Linder M, Sanyal A